Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages

Retrovirology

Volumn 9, Issue , 2012, Pages

  Contreras, Xavier ^a,c,d   Mzoughi, Olfa ^a,b   Gaston, Fabrice ^a,b   Peterlin, Matija B ^c   Bahraoui, Elmostafa ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU PURPAN   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PROTEIN KINASE C DELTA;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; PHARMACOLOGICAL BLOCKING; REVERSE TRANSCRIPTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ACETOPHENONES; ACTIN CYTOSKELETON; ANTIGENS, CD4; BENZOPYRANS; DNA, COMPLEMENTARY; HELA CELLS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; ISOENZYMES; MACROPHAGES; PROTEIN KINASE C-DELTA; RECEPTORS, CCR5; REVERSE TRANSCRIPTION; RNA, SMALL INTERFERING; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84860376937     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-37     Document Type: Article

References (64)

1. Hirsch V, Sharkey M, Brown C, Brichacek B, Goldstein S, Wakefield J, Byrum R, Elkins W, Hahn B, Lifson J, Stevenson M. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med 1998, 4:1401-1408. 10.1038/3992, 9846578.
2. Hu Q, Frank I, Williams V, Santos JJ, Watts P, Griffin GE, Moore JP, Pope M, Shattock RJ. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 2004, 199:1065-1075. 10.1084/jem.20022212, 2211899, 15078900.
3. Embretson J, Zupancic M, Ribas J, Burke A, Racz P, Tenner-Racz K, Haase A. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-362. 10.1038/362359a0, 8096068.
4. Orenstein J, Fox C, Wahl S. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861. 10.1126/science.276.5320.1857, 9188531.
5. Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 1999, 5:204-210. 10.1038/5568, 9930869.
6. Llewellyn N, Zioni R, Zhu H, Andrus T, Xu Y, Corey L, Zhu T. Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J Leukoc Biol 2006, 80:1118-1126. 10.1189/jlb.0306144, 17056765.
7. Briand G, Barbeau B, Tremblay M. Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology 1997, 228:171-179. 10.1006/viro.1996.8399, 9123823.
8. Davis C, Dikic I, Unutmaz D, Hill C, Arthos J, Siani M, Thompson D, Schlessinger J, Littman D. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997, 186:1793-1798. 10.1084/jem.186.10.1793, 2199136, 9362541.
9. Harmon B, Ratner L. Induction of the G{alpha}q Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry. J Virol Am Soc Microbiol 2008, 82:9191.
10. Popik W, Hesselgesser J, Pitha P. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 1998, 72:6406-6413. 109793, 9658081.
11. Popik W, Alce TM, Au W-C. Human Immunodeficiency Virus Type 1 Uses Lipid Raft-Colocalized CD4 and Chemokine Receptors for Productive Entry into CD4+ T Cells. J Virol Am Soc Microbiol 2002, 76:4709-4722.
12. Veillette A, Bookman M, Horak E, Samelson L, Bolen J. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature 1989, 338:257-259. 10.1038/338257a0, 2784195.
13. Francois F, Klotman M. Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages. J Virol 2003, 77:2539-2549. 10.1128/JVI.77.4.2539-2549.2003, 141101, 12551992.
14. Harmon B, Campbell N, Ratner L. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog 2010, 6:e1000956. 10.1371/journal.ppat.1000956, 2887473, 20585556.
15. Hassaine G, Courcoul M, Bessou G, Barthalay Y, Picard C, Olive D, Collette Y, Vigne R, Decroly E. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J Biol Chem 2001, 276:16885-16893. 10.1074/jbc.M009076200, 11278465.
16. Mettling C, Desmetz C, Fiser A-L, Réant B, Corbeau P, Lin Y-L. Gαi protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription. AIDS 2008, 22:1569-1576. 10.1097/QAD.0b013e32830abdaf, 18670215.
17. Schubert U, Schneider T, Henklein P, Hoffmann K, Berthold E, Hauser H, Pauli G, Porstmann T. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur J Biochem 1992, 204:875-883. 10.1111/j.1432-1033.1992.tb16707.x, 1541298.
18. Vita C. Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein. Proc Natl Acad Sci 1999, 96:13091-13096. 10.1073/pnas.96.23.13091, 23905, 10557278.
19. Yang X, Gabuzda D. Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. J Biol Chem 1998, 273:29879-29887. 10.1074/jbc.273.45.29879, 9792705.
20. Hamamoto Y, Matsuyama T, Yamamoto N, Kobayashi N. Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor. Cancer Res 1990, 50:5287-5290.
21. Meichle A, Schutze S, Hensel G, Brunsing D, Kronke M. Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor. J Biol Chem 1990, 265:8339-8343.
22. Wei P, Garber M, Fang S, Fischer W, Jones K. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462. 10.1016/S0092-8674(00)80939-3, 9491887.
23. Griffin GE, Leung K, Folks TM, Kunkel S, Nabel GJ. Activation of HIV gene expression during monocyte differentiation by induction of NF-kB. Nature. Nature Publishing Group 1989, 339:70-73.
24. Lamph W, Wamsley P, Sassone-Corsi P, Verma I. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 1988, 334:629-631. 10.1038/334629a0, 2457172.
25. Siekevitz M, Josephs S, Dukovich M, Peffer N, Wong-Staal F, Greene W. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 1987, 238:1575-1578. 10.1126/science.2825351, 2825351.
26. Burnette B, Yu G, Felsted R. Phosphorylation of HIV-1 gag proteins by protein kinase C. J Biol Chem 1993, 268:8698-8703.
27. Baur AS, Sass G, Laffert B, Willbold D, Cheng-Mayer C, Peterlin BM. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 1997, 6:283-291. 10.1016/S1074-7613(00)80331-3, 9075929.
28. Guy B, Kieny M, Riviere Y, Le Peuch C, Dott K, Girard M, Montagnier L, Lecocq J. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 1987, 330:266-269. 10.1038/330266a0, 3118220.
29. Guy B, Riviere Y, Dott K, Regnault A, Kieny M. Mutational analysis of the HIV nef protein. Virology 1990, 176:413-425. 10.1016/0042-6822(90)90011-F, 2111956.
30. Malim MH, Böhnlein S, Hauber J, Cullen BR. Functional dissection of the HIV-1 Rev trans-activator-Derivation of a trans-dominant repressor of Rev function. Cell 1989, 58:205-214. 10.1016/0092-8674(89)90416-9, 2752419.
31. Breitkreutz D, Braiman-Wiksman L, Daum N, Denning M, Tennenbaum T. Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J Cancer Res Clin Oncol 2007, 133:793-808. 10.1007/s00432-007-0280-3, 17661083.
32. Ron D, Kazanietz M. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 1999, 13:1658-1676.
33. Sonza S, Maerz A, Deacon N, Meanger J, Mills J, Crowe S. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 1996, 70:3863-3869. 190263, 8648722.
34. Sonza S, Mutimer H, Oelrichs R, Jardine D, Harvey K, Dunne A, Purcell D, Birch C, Crowe S. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 2001, 15:17-22. 10.1097/00002030-200101050-00005, 11192864.
35. Fantuzzi L, Conti L, Gauzzi M, Eid P, del Corno M, Varano B, Canini I, Belardelli F, Gessani S. Regulation of chemokine/cytokine network during in vitro differentiation and HIV-1 infection of human monocytes: possible importance in the pathogenesis of AIDS. J Leukoc Biol 2000, 68:391-399.
36. Weiden M, Tanaka N, Qiao Y, Zhao B, Honda Y, Nakata K, Canova A, Levy D, Rom W, Pine R. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 2000, 165:2028-2039.
37. Junttila I, Bourette R, Rohrschneider L, Silvennoinen O. M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-delta and expression of Pkare. J Leukoc Biol 2003, 73:281-288. 10.1189/jlb.0702359, 12554805.
38. Kang H, Park E, Kim K, Park J, Choi J, Shin H, Jun C, Kang S, Kim S. Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation. Mol Cells 2004, 17:438-445.
39. Mischak H, Pierce J, Goodnight J, Kazanietz M, Blumberg P, Mushinski J. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. J Biol Chem 1993, 268:20110-20115.
40. Biswas D, Ahlers C, Dezube B, Pardee A. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol Med 1994, 1:31-43. 2229934, 8790599.
41. Owen P, Johnson G, Lord J. Protein kinase C-delta associates with vimentin intermediate filaments in differentiated HL60 cells. Exp Cell Res 1996, 225:366-373. 10.1006/excr.1996.0187, 8660925.
42. Lopez-Lluch G, Bird M, Canas B, Godovac-Zimmerman J, Ridley A, Segal A, Dekker L. Protein kinase C-delta C2-like domain is a binding site for actin and enables actin redistribution in neutrophils. Biochem J 2001, 357:39-47. 10.1042/0264-6021:3570039, 1221926, 11415434.
43. Smallwood N, Hausman B, Wang X, Liedtke C. Involvement of NH2 terminus of PKC-delta in binding to F-actin during activation of Calu-3 airway epithelial NKCC1. Am J Physiol Cell Physiol 2005, 288:C906-C912.
44. Lopez-Huertas MR, Mateos E, Diaz-Gil G, Gomez-Esquer F, Sanchez Del Cojo M, Alcami J, Coiras M. Protein kinase C (PKC) theta ({theta}) is a specific target for the inhibition of the human immunodeficiency virus type 1 (HIV-1) replication in CD4+ T lymphocytes. J Biol Chem 2011, 286:27363-27377. 10.1074/jbc.M110.210443, 3149330, 21669868.
45. Lemjabbar-Alaoui H, Sidhu SS, Mengistab A, Gallup M, Basbaum C. TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells. PLoS One 2011, 6:e17489. 10.1371/journal.pone.0017489, 3057966, 21423656.
46. Bennasser Y, Bahraoui E. HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta. FASEB J 2002, 16:546-554. 10.1096/fj.01-0775com, 11919157.
47. Bukrinskaya A. Establishment of a Functional Human Immunodeficiency Virus Type 1(HIV-1) Reverse Transcription Complex Involves the Cytoskeleton. J Exper Med 1998, 188:2113-2125.
48. Mzoughi O, Gaston F, Granados GC, Lakhdar-Ghazal F, Giralt E, Bahraoui E. Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies. ChemMedChem 2010, 5:1907-1918. 10.1002/cmdc.201000313, 20922745.
49. Campbell E, Nunez R, Hope T. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J Virol 2004, 78:5745-5755. 10.1128/JVI.78.11.5745-5755.2004, 415815, 15140972.
50. Warrilow D, Gardner J, Darnell GA, Suhrbier A. Harrich D. HIV Type 1 Inhibition by Protein Kinase C Modulatory Compounds. 2004, 22:854-864. Mary Ann Liebert, Inc. 2 Madison Avenue Larchmont, NY 10538 USA;2006.
51. Williams S, Chen L, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene W. Prostratin antagonizes HIV latency by activating NF-kappaB. J Biol Chem 2004, 279:42008-42017. 10.1074/jbc.M402124200, 15284245.
52. Wu Y, Yoder A. Chemokine co-receptor signaling in HIV-1 infection and pathogenesis. PLoS Pathog 2009, 5:e1000520. 10.1371/journal.ppat.1000520, 2790611, 20041213.
53. Arhel N, Genovesio A, Kim K-A, Miko S, Perret E, Olivo-Marin J-C, Shorte S, Charneau P. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods 2006, 3:817-824. 10.1038/nmeth928, 16990814.
54. Michael H, Gramatikoff K, Georgiev O, Chaponnier C, Schaffner W, Hübscher U. The large subunit of HIV-1 reverse transcriptase interacts with β-actin. Nucleic Acids Res 1995, 23:736-741. 10.1093/nar/23.5.736, 306752, 7535922.
55. Iyengar S, Hildreth J, Schwartz D. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol 1998, 72:5251-5255. 110111, 9573299.
56. Cameron PU, Saleh S, Sallmann G, Solomon A, Wightman F, Evans VA, Boucher G, Haddad EK, Sekaly R-P, Harman AN, Anderson JL, Jones KL, Mak J, Cunningham AL, Jaworowski A, Lewin SR. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci USA 2010, 107:16934-16939. 10.1073/pnas.1002894107, 2947912, 20837531.
57. Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, Yu D, Spear M, Wu Y. LIM Kinase 1 Modulates Cortical Actin and CXCR4 Cycling and Is Activated by HIV-1 to Initiate Viral Infection. J Biol Chem 2011, 286:12554-12564. 10.1074/jbc.M110.182238, 3069457, 21321123.
58. Yoder A, Yu D, Dong L, Iyer SR, Xu X, Kelly J, Liu J, Wang W, Vorster PJ, Agulto L, Stephany DA, Cooper JN, Marsh JW, Wu Y. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008, 134:782-792. 10.1016/j.cell.2008.06.036, 2559857, 18775311.
59. Komano J, Miyauchi K, Matsuda Z, Yamamoto N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol Biol Cell 2004, 15:5197-5207. 10.1091/mbc.E04-04-0279, 532003, 15385624.
60. Naghavi MH, Valente S, Hatziioannou T, de Los Santos K, Wen Y, Mott C, Gundersen GG, Goff SP. Moesin regulates stable microtubule formation and limits retroviral infection in cultured cells. EMBO J 2007, 26:41-52. 10.1038/sj.emboj.7601475, 1782362, 17170707.
61. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137:433-444. 10.1016/j.cell.2009.02.046, 2696170, 19410541.
62. Turlure F, Devroe E, Silver PA, Engelman A. Human cell proteins and human immunodeficiency virus DNA integration. Front Biosci 2004, 9:3187-3208. 10.2741/1472, 15353349.
63. Wilk T, Gowen B, Fuller SD. Actin Associates with the Nucleocapsid Domain of the Human Immunodeficiency Virus Gag Polyprotein. J Virol Am Soc Microbiol 1999, 73:1931-1940.
64. Torgersen ML, Wälchli S, Grimmer S, Skånland SS, Sandvig K. Protein kinase Cdelta is activated by Shiga toxin and regulates its transport. J Biol Chem 2007, 282:16317-16328. 10.1074/jbc.M610886200, 17403690.